Life ScienceCompany
Impax Laboratories - Generic Products and Assets Ownership
Who owns Impax Laboratories - Generic Products and Assets?
Impax Laboratories - Generic Products and Assets is owned by ANI Pharmaceuticals. It was acquired on April 27, 2018.
Impax Laboratories - Generic Products and Assets Business Overview
Where is Impax Laboratories - Generic Products and Assets headquartered?
Impax Laboratories - Generic Products and Assets is headquartered in Hayward, California.
What sector is Impax Laboratories - Generic Products and Assets in?
Impax Laboratories - Generic Products and Assets is a life science company.
Life Science M&A Summary in 2018
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2018. The largest life science acquisition in 2018 was Shire - which was acquired by Takeda Pharmaceutical for $67.7B.
Join Mergr to view all 246 acquisitions of life science companies in 2018, including 44 acquisitions by private equity firms, and 202 by strategics.